Oncology News

In a new study, alpha-fetoprotein measurement in combination with ultrasound improved surveillance effectiveness in patients with cirrhosis, according to published data in The American Journal of Gastroenterology.

In a phase 2 clinical study, patients with advanced hepatocellular carcinoma displayed improved progression-free survival and time to progression survival rates after treatment with bavituximab and nexavar, according to data presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.

Percutaneous hepatic perfusion increased hepatic progression free and overall survival rates in patients with liver metastases from melanoma vs. patients who underwent yttrium-90 therapy, according to data presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.

In a retrospective study, researchers used Caris Molecular Intelligence to identify molecular patterns and therapeutic options for hepatocellular carcinoma and presented the data at the 68th Annual Cancer Symposium of the Society of Surgical Oncology in Houston, according to a news release.

In a phase 2 clinical trial, antineoplastons, such as A10 injection and AS2-1, were a useful form of adjunctive therapy after hepatic arterial infusion, and improved cancer-specific survival in patients with liver metastases from colorectal cancer, according to study data.

Parenchymal preservation reduced mortality rate and complications in patients who underwent hepatectomy for malignancies, according to newly published data. 

Carbonic anhydrase IX, or CA-IX, expression was a crucial prognostic factor in predicting overall survival and disease-free survival in resectable hepatocellular carcinoma, according to study data.

The SARAH Study, a large French study of patients with advanced, inoperable hepatocellular carcinoma, has completed enrollment with more than 400 patients and expects results to be available in 2016, according to a press release.

Reduced cold and warm ischemia times could decrease the risk for hepatocellular carcinoma recurrence after liver transplantation, according to data published in Hepatology.

Nearly 500,000 Americans are projected to be diagnosed with obesity-associated cancers annually by 2030, according to an ASCO press release.